SOURCE: IndigoStocks.com

May 23, 2005 07:30 ET

IndigoStocks.com Rates the Following Stocks for Monday, May 23, 2005: AMGN, GENZ, SYK, and YHOO

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by IndigoStocks.com.

ATLANTA, GA -- (MARKET WIRE) -- May 23, 2005 -- IndigoStocks.com has a long-term buy rating on Amgen, Inc. (NASDAQ: AMGN) and a short-term buy rating on Genzyme Corp. (NASDAQ: GENZ), Stryker Corp. (NYSE: SYK), and Yahoo! Inc. (NASDAQ: YHOO).

Amgen, Inc. is a global biotechnology company that discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology.

Genzyme Corp. is a global biotechnology company that operates in five segments: renal, therapeutics, transplant, biosurgery, and diagnostics/genetics.

Stryker Corp. manufactures and markets medical devices primarily to the orthopedic market.

Yahoo! Inc. together with its consolidated subsidiaries, is a global Internet brand.

On Friday, May 20, 2005 the stocks closed as follows:

AMGN $61.87 up 0.08%
GENZ $63.84 down 0.25%
SYK $48.39 up 0.33%
YHOO $36.33 down 1.14%.
About IndigoStocks.com: IndigoStocks owns and operates a financial news website for a range of investors from active traders to more conservative investors. IndigoStocks.com collects information from a wide variety of publicly available sources to produce its reports. Via e-mail to our subscribers, we issue one daily report for short-term stock selections, a weekly longer-term selection, and a weekly recap and a 'Looking Ahead' at the upcoming week.

DISCLAIMER: IndigoStocks does not offer market advice on an individual basis. Investment in the equity market entails a certain level of risk. Only the individual investor can determine what level of risk is acceptable to his or her financial situation. Our personnel may own positions in the equities mentioned in our reports. However, all employees are prohibited from any transaction that directly or indirectly competes with the interests of our subscribers. We are not compensated in any way for publishing information about companies mentioned in our reports. See our website for the full disclaimer.

Contact Information